NC
TECX

Nexthera Capital’s Tectonic Therapeutic TECX Stock Holding History

Nexthera Capital’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-833
Closed -$286K – 67
2018
Q2 		$286K Buy
+833
New +$300K 0.04% 45

Other funds holding TECX

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nexthera Capital's TECX Position: Q3 2018 in Review

Nexthera Capital sold out of Tectonic Therapeutic (TECX) in Q3 2018, closing a stake of 833 shares — an estimated $286K sold.

Nexthera Capital first reported a position in TECX in Q2 2018 and held it in 1 quarter. The position peaked at $286K in Q2 2018. 63 funds tracked by Wall St. Rank hold TECX as of Q3 2018.

  • Nexthera Capital reported no remaining Tectonic Therapeutic position as of Q3 2018 after selling out during the quarter.
  • Nexthera Capital sold 833 Tectonic Therapeutic shares in Q3 2018, an estimated $286K.
  • Nexthera Capital first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 1 quarter.
  • Nexthera Capital's Tectonic Therapeutic position peaked at $286K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2018.

Based on Nexthera Capital's 13F filing for Q3 2018, filed 14 Nov 2018.